{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:44:16Z","timestamp":1789703056767,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T00:00:00Z","timestamp":1530057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Science Foundation, China","award":["81401663"],"award-info":[{"award-number":["81401663"]}]},{"name":"Health and Family Planning Commission of HuBei Province, China","award":["XF2012-22"],"award-info":[{"award-number":["XF2012-22"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00436-018-5972-x","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T22:34:55Z","timestamp":1530052495000},"page":"2831-2839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Sorafenib and praziquantel synergistically attenuate Schistosoma japonicum-induced liver fibrosis in mice"],"prefix":"10.1007","volume":"117","author":[{"given":"Zhiyong","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,27]]},"reference":[{"key":"5972_CR1","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/j.1365-3024.2009.01157.x","volume":"31","author":"ZA Andrade","year":"2009","unstructured":"Andrade ZA (2009) Schistosomiasis and liver fibrosis. Parasite Immunol 31:656\u2013663. \n                    https:\/\/doi.org\/10.1111\/j.1365-3024.2009.01157.x","journal-title":"Parasite Immunol"},{"key":"5972_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115:209\u2013218. \n                    https:\/\/doi.org\/10.1172\/JCI24282","journal-title":"J Clin Invest"},{"key":"5972_CR3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ijpara.2010.01.007","volume":"40","author":"S Beckmann","year":"2010","unstructured":"Beckmann S, Grevelding CG (2010) Imatinib has a fatal impact on morphology, pairing stability and survival of adult Schistosoma mansoni in vitro. Int J Parasitol 40:521\u2013526. \n                    https:\/\/doi.org\/10.1016\/j.ijpara.2010.01.007","journal-title":"Int J Parasitol"},{"key":"5972_CR4","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/labinvest.3700094","volume":"84","author":"E Borkham-Kamphorst","year":"2004","unstructured":"Borkham-Kamphorst E, Herrmann J, Stoll D, Treptau J, Gressner AM, Weiskirchen R (2004) Dominant-negative soluble PDGF-beta receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis. Lab Investig 84:766\u2013777. \n                    https:\/\/doi.org\/10.1038\/labinvest.3700094","journal-title":"Lab Investig"},{"key":"5972_CR5","doi-asserted-by":"publisher","first-page":"e2923","DOI":"10.1371\/journal.pntd.0002923","volume":"8","author":"C Buro","year":"2014","unstructured":"Buro C, Beckmann S, Oliveira KC, Dissous C, Cailliau K, Marh\u00f6fer RJ, Selzer PM, Verjovski-Almeida S, Grevelding CG (2014) Imatinib treatment causes substantial transcriptional changes in adult Schistosoma mansoni in vitro exhibiting pleiotropic effects. PLoS Negl Trop Dis 8:e2923. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0002923","journal-title":"PLoS Negl Trop Dis"},{"key":"5972_CR6","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3748\/wjg.v19.i9.1405","volume":"19","author":"BL Chen","year":"2013","unstructured":"Chen BL, Peng J, Li QF, Yang M, Wang Y, Chen W (2013) Exogenous bone morphogenetic protein-7 reduces hepatic fibrosis in Schistosoma japonicum-infected mice via transforming growth factor-beta\/Smad signaling. World J Gastroenterol 19:1405\u20131415. \n                    https:\/\/doi.org\/10.3748\/wjg.v19.i9.1405","journal-title":"World J Gastroenterol"},{"key":"5972_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.molbiopara.2014.06.002","volume":"195","author":"D Cioli","year":"2014","unstructured":"Cioli D, Pica-Mattoccia L, Basso A, Guidi A (2014) Schistosomiasis control: praziquantel forever? Mol Biochem Parasitol 195:23\u201329. \n                    https:\/\/doi.org\/10.1016\/j.molbiopara.2014.06.002","journal-title":"Mol Biochem Parasitol"},{"key":"5972_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/pim.12087","volume":"36","author":"DG Colley","year":"2014","unstructured":"Colley DG, Secor WE (2014) Immunology of human schistosomiasis. Parasite Immunol 36:347\u2013357. \n                    https:\/\/doi.org\/10.1111\/pim.12087","journal-title":"Parasite Immunol"},{"key":"5972_CR9","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","volume":"383","author":"DG Colley","year":"2014","unstructured":"Colley DG, Bustinduy AL, Secor WE, King CH (2014) Human schistosomiasis. Lancet 383:2253\u20132264. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(13)61949-2","journal-title":"Lancet"},{"key":"5972_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaut.2013.07.008","volume":"46","author":"YR Deng","year":"2013","unstructured":"Deng YR et al (2013) STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib. J Autoimmun 46:25\u201334. \n                    https:\/\/doi.org\/10.1016\/j.jaut.2013.07.008","journal-title":"J Autoimmun"},{"key":"5972_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/QCO.0b013e328318978f","volume":"21","author":"MJ Doenhoff","year":"2008","unstructured":"Doenhoff MJ, Cioli D, Utzinger J (2008) Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 21:659\u2013667. \n                    https:\/\/doi.org\/10.1097\/QCO.0b013e328318978f","journal-title":"Curr Opin Infect Dis"},{"key":"5972_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10787-011-0092-6","volume":"19","author":"DS El-Agamy","year":"2011","unstructured":"El-Agamy DS, Shebl AM, Said SA (2011) Prevention and treatment of Schistosoma mansoni-induced liver fibrosis in mice. Inflammopharmacology 19:307\u2013316. \n                    https:\/\/doi.org\/10.1007\/s10787-011-0092-6","journal-title":"Inflammopharmacology"},{"key":"5972_CR13","doi-asserted-by":"publisher","first-page":"12719","DOI":"10.1073\/pnas.96.22.12719","volume":"96","author":"J George","year":"1999","unstructured":"George J, Roulot D, Koteliansky VE, Bissell DM (1999) In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis. Proc Natl Acad Sci U S A 96:12719\u201312724","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5972_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1517\/14656566.2011.546346","volume":"12","author":"YS Guan","year":"2011","unstructured":"Guan YS, He Q (2011) Sorafenib: activity and clinical application in patients with hepatocellular carcinoma. Expert Opin Pharmacother 12:303\u2013313. \n                    https:\/\/doi.org\/10.1517\/14656566.2011.546346","journal-title":"Expert Opin Pharmacother"},{"key":"5972_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/labinvest.2010.148","volume":"91","author":"M Hennenberg","year":"2011","unstructured":"Hennenberg M et al (2011) Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis. Lab Investig 91:241\u2013251. \n                    https:\/\/doi.org\/10.1038\/labinvest.2010.148","journal-title":"Lab Investig"},{"key":"5972_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2147\/JHC.S45040","volume":"1","author":"CH Hsu","year":"2014","unstructured":"Hsu CH, Shen YC, Shao YY, Hsu C, Cheng AL (2014) Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives. J Hepatocell Carcinoma 1:85\u201399. \n                    https:\/\/doi.org\/10.2147\/JHC.S45040","journal-title":"J Hepatocell Carcinoma"},{"key":"5972_CR17","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/j.1478-3231.2012.02806.x","volume":"32","author":"Y Kim","year":"2012","unstructured":"Kim Y, Fiel MI, Albanis E, Chou HI, Zhang W, Khitrov G, Friedman SL (2012) Anti-fibrotic activity and enhanced interleukin-6 production by hepatic stellate cells in response to imatinib mesylate. Liver Int 32:1008\u20131017. \n                    https:\/\/doi.org\/10.1111\/j.1478-3231.2012.02806.x","journal-title":"Liver Int"},{"key":"5972_CR18","doi-asserted-by":"publisher","first-page":"e20247","DOI":"10.1371\/journal.pone.0020247","volume":"6","author":"YJ Liang","year":"2011","unstructured":"Liang YJ, Luo J, Yuan Q, Zheng D, Liu YP, Shi L, Zhou Y, Chen AL, Ren YY, Sun KY, Sun Y, Wang Y, Zhang ZS (2011) New insight into the antifibrotic effects of praziquantel on mice in infection with Schistosoma japonicum. PLoS One 6:e20247. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0020247","journal-title":"PLoS One"},{"key":"5972_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12876-015-0380-5","volume":"15","author":"C Liu","year":"2015","unstructured":"Liu C, Yang Z, Wang L, Lu Y, Tang B, Miao H, Xu Q, Chen X (2015) Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats. BMC Gastroenterol 15:159. \n                    https:\/\/doi.org\/10.1186\/s12876-015-0380-5","journal-title":"BMC Gastroenterol"},{"key":"5972_CR20","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/hep.22758","volume":"49","author":"M Mejias","year":"2009","unstructured":"Mejias M, Garcia-Pras E, Tiani C, Miquel R, Bosch J, Fernandez M (2009) Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats. Hepatology 49:1245\u20131256. \n                    https:\/\/doi.org\/10.1002\/hep.22758","journal-title":"Hepatology"},{"key":"5972_CR21","unstructured":"Moreira RK (2007) Hepatic stellate cells and liver fibrosis. Arch Pathol Lab Med 131:1728\u20131734. https:\/\/doi.org\/10.1043\/1543-2165(2007)131[1728:HSCALF]2.0.CO;2"},{"issue":"Suppl 1","key":"5972_CR22","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1111\/j.1440-1746.2006.04659.x","volume":"22","author":"CJ Parsons","year":"2007","unstructured":"Parsons CJ, Takashima M, Rippe RA (2007) Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol Hepatol 22(Suppl 1):S79\u2013S84. \n                    https:\/\/doi.org\/10.1111\/j.1440-1746.2006.04659.x","journal-title":"J Gastroenterol Hepatol"},{"key":"5972_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1247\/csf.28.105","volume":"28","author":"M Sato","year":"2003","unstructured":"Sato M, Suzuki S, Senoo H (2003) Hepatic stellate cells: unique characteristics in cell biology and phenotype. Cell Struct Funct 28:105\u2013112","journal-title":"Cell Struct Funct"},{"key":"5972_CR24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1365-3024.2005.00778.x","volume":"27","author":"WE Secor","year":"2005","unstructured":"Secor WE (2005) Immunology of human schistosomiasis: off the beaten path. Parasite Immunol 27:309\u2013316. \n                    https:\/\/doi.org\/10.1111\/j.1365-3024.2005.00778.x","journal-title":"Parasite Immunol"},{"key":"5972_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.exppara.2018.01.013","volume":"185","author":"MMK Sobhy","year":"2018","unstructured":"Sobhy MMK, Mahmoud SS, El-Sayed SH, Rizk EMA, Raafat A, Negm MSI (2018) Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection. Exp Parasitol 185:115\u2013123. \n                    https:\/\/doi.org\/10.1016\/j.exppara.2018.01.013","journal-title":"Exp Parasitol"},{"key":"5972_CR26","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1073\/pnas.1507499112","volume":"112","author":"TH Su","year":"2015","unstructured":"Su TH et al (2015) Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition. Proc Natl Acad Sci U S A 112:7243\u20137248. \n                    https:\/\/doi.org\/10.1073\/pnas.1507499112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5972_CR27","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/hep.24427","volume":"54","author":"D Thabut","year":"2011","unstructured":"Thabut D, Routray C, Lomberk G, Shergill U, Glaser K, Huebert R, Patel L, Masyuk T, Blechacz B, Vercnocke A, Ritman E, Ehman R, Urrutia R, Shah V (2011) Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis. Hepatology 54:573\u2013585. \n                    https:\/\/doi.org\/10.1002\/hep.24427","journal-title":"Hepatology"},{"key":"5972_CR28","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00436-017-5392-3","volume":"116","author":"C Wan","year":"2017","unstructured":"Wan C, Jin F, Du Y, Yang K, Yao L, Mei Z, Huang W (2017) Genistein improves schistosomiasis liver granuloma and fibrosis via dampening NF-kB signaling in mice. Parasitol Res 116:1165\u20131174. \n                    https:\/\/doi.org\/10.1007\/s00436-017-5392-3","journal-title":"Parasitol Res"},{"key":"5972_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jhep.2010.02.027","volume":"53","author":"Y Wang","year":"2010","unstructured":"Wang Y, Gao J, Zhang D, Zhang J, Ma J, Jiang H (2010) New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol 53:132\u2013144. \n                    https:\/\/doi.org\/10.1016\/j.jhep.2010.02.027","journal-title":"J Hepatol"},{"key":"5972_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00167","volume":"5","author":"J Xu","year":"2014","unstructured":"Xu J, Liu X, Koyama Y, Wang P, Lan T, Kim IG, Kim IH, Ma HY, Kisseleva T (2014) The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies. Front Pharmacol 5:167. \n                    https:\/\/doi.org\/10.3389\/fphar.2014.00167","journal-title":"Front Pharmacol"},{"key":"5972_CR31","first-page":"899","volume":"17","author":"H Yoshiji","year":"2006","unstructured":"Yoshiji H, Kuriyama S, Noguchi R, Ikenaka Y, Yoshii J, Yanase K, Namisaki T, Kitade M, Yamazaki M, Asada K, Akahane T, Tsujimoto T, Uemura M, Fukui H (2006) Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in rats. Int J Mol Med 17:899\u2013904","journal-title":"Int J Mol Med"},{"key":"5972_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.actatropica.2005.07.005","volume":"96","author":"XN Zhou","year":"2005","unstructured":"Zhou XN et al (2005) The public health significance and control of schistosomiasis in China\u2014then and now. Acta Trop 96:97\u2013105. \n                    https:\/\/doi.org\/10.1016\/j.actatropica.2005.07.005","journal-title":"Acta Trop"},{"key":"5972_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13071-015-0640-9","volume":"8","author":"D Zhu","year":"2015","unstructured":"Zhu D, Song K, Chen J, Wang J, Sun X, Qian H, Gu X, Zhang L, Qin Y, Duan Y (2015) Expression of Septin4 in Schistosoma japonicum-infected mouse livers after praziquantel treatment. Parasit Vectors 8:19. \n                    https:\/\/doi.org\/10.1186\/s13071-015-0640-9","journal-title":"Parasit Vectors"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-018-5972-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-018-5972-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-018-5972-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T23:15:06Z","timestamp":1561590906000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-018-5972-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,27]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["5972"],"URL":"https:\/\/doi.org\/10.1007\/s00436-018-5972-x","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,27]]},"assertion":[{"value":"26 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All animals were maintained according to the guidelines of the animal facility at the Hubei Provincial Academy of Preventive Medicine. All animal experiments were conducted in accordance with the Guide for the Care and Use of Laboratory and approved by the Committee on the Ethics of Animal Experiments of Hubei Provincial Academy of Preventive Medicine (project number M2014001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets supporting the conclusions of this article are included within the article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of the data and materials"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}